Alumis (ALMS) Total Non-Current Liabilities (2023 - 2025)

Alumis (ALMS) reported Total Non-Current Liabilities of $110.5 million for Q4 2025, up 38.02% year-over-year from $80.1 million in Q4 2024, and up 7.23% quarter-over-quarter from $103.1 million in Q3 2025.

Alumis (ALMS) Total Non-Current Liabilities (2023 - 2025) Analysis & Trends

Alumis (ALMS) has 3 years of Total Non-Current Liabilities data on file, last reported at $110.5 million in Q4 2025.

  • Total Non-Current Liabilities for Q4 2025 came in at $110.5 million, up 38.02% year-over-year; the trailing twelve-month figure through Dec 2025 was $110.5 million (up 38.02% YoY), and the FY2025 annual result was $110.5 million, up 38.02% from the prior year.
  • Total Non-Current Liabilities advanced to $110.5 million in Q4 2025 per ALMS's latest filing, from $103.1 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $125.2 million in Q2 2025 and troughed at $51.7 million in Q4 2023.
  • A 3-year average of $86.2 million and a median of $86.2 million in 2024 frame the typical range for Total Non-Current Liabilities.
  • On a YoY basis, Total Non-Current Liabilities climbed as much as 97.3% in 2025 and fell as far as 38.02% in 2025.
  • A 3-year view of Total Non-Current Liabilities shows it stood at $51.7 million in 2023, then surged by 54.79% to $80.1 million in 2024, then soared by 38.02% to $110.5 million in 2025.
  • Business Quant data shows ALMS's Total Non-Current Liabilities at $110.5 million in Q4 2025, $103.1 million in Q3 2025, and $125.2 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 42,980.09
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 11.03 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 95.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.87 Bn
9 Abivax 91.96 Bn 91.96 Bn - 64.76 Mn
10 Alumis 1.99 Bn 1.90 Bn - 110.52 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 110.52 Mn
Sep 30, 2025 103.07 Mn
Jun 30, 2025 125.21 Mn
Mar 31, 2025 92.40 Mn
Dec 31, 2024 80.08 Mn
Sep 30, 2024 63.15 Mn
Jun 30, 2024 63.46 Mn
Dec 31, 2023 51.73 Mn